B Robertson Selected Research

poractant alfa (Curosurf)

1/2008	Therapeutic effects of exogenous surfactant enriched with dextran in newborn rabbits with respiratory failure induced by airway instillation of albumin.
1/2005	Biophysical and physiological properties of porcine surfactant enriched with polymyxin B.
1/2004	Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia.
4/2000	Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B Robertson Research Topics

Disease

9	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 09/2003 - 04/2000
7	Respiratory Insufficiency (Respiratory Failure) 01/2008 - 02/2000
6	Infections 03/2007 - 05/2000
5	Pneumonia (Pneumonitis) 01/2004 - 01/2000
2	Neoplasms (Cancer) 09/2018 - 01/2014
2	Lung Injury 10/2001 - 08/2000
2	Acute Lung Injury 08/2000 - 02/2000
2	Lung Diseases (Lung Disease) 03/2000 - 01/2000
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2018
1	Retinoblastoma (Glioblastoma, Retinal) 01/2014
1	Mental Fatigue 03/2008
1	Thrombosis (Thrombus) 08/2007
1	Malaria 03/2007
1	Pneumothorax 01/2005
1	Hyperalgesia 01/2003
1	Pain (Aches) 01/2003
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2002
1	Surfactant Dysfunction 01/2002
1	Psychomotor Disorders 04/2001
1	Chronic Disease (Chronic Diseases) 02/2001
1	Pneumococcal Pneumonia 01/2001
1	Waterborne Diseases 12/2000
1	Streptococcal Infections (Streptococcal Infection) 11/2000
1	Cryptococcosis 09/2000
1	Bacterial Infections (Bacterial Infection) 09/2000
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2000
1	Newborn Respiratory Distress Syndrome 04/2000
1	Birth Weight (Birth Weights) 04/2000

Drug/Important Bio-Agent (IBA)

20	Surface-Active Agents (Surfactants)IBA 01/2008 - 01/2000
4	poractant alfa (Curosurf)FDA Link 01/2008 - 04/2000
2	AlbuminsIBA 01/2008 - 01/2005
2	Vitamin E FDA LinkGeneric 01/2004 - 01/2000
2	AntioxidantsIBA 01/2004 - 01/2000
2	EndotoxinsIBA 10/2001 - 02/2000
2	PolymersIBA 10/2001 - 08/2000
2	beractant (Survanta)FDA Link 10/2001 - 08/2000
1	Retinoblastoma ProteinIBA 01/2014
1	Glutamine (L-Glutamine)FDA Link 01/2014
1	MineralsIBA 03/2008
1	VitaminsIBA 03/2008
1	Dextrans (Dextran)FDA Link 01/2008
1	Therapeutic UsesIBA 01/2008
1	Antiphospholipid AntibodiesIBA 08/2007
1	Janus Kinase 2IBA 08/2007
1	Mefloquine (Lariam)FDA LinkGeneric 03/2007
1	Adenosine (Adenocard)FDA LinkGeneric 01/2003
1	Adenosine A1 ReceptorIBA 01/2003
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2001
1	LipopolysaccharidesIBA 10/2001
1	Proteins (Proteins, Gene)FDA Link 07/2001
1	Propofol (Diprivan)FDA LinkGeneric 04/2001
1	Fentanyl (Sublimaze)FDA LinkGeneric 04/2001
1	Midazolam (Versed)FDA LinkGeneric 04/2001
1	Tight Junction ProteinsIBA 02/2001
1	Glucose (Dextrose)FDA LinkGeneric 02/2001
1	Drinking WaterIBA 12/2000
1	Protein CIBA 11/2000
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 08/2000
1	Blood Proteins (Serum Proteins)IBA 08/2000
1	AntigensIBA 05/2000
1	Interferon gamma ReceptorIBA 05/2000
1	CytokinesIBA 05/2000
1	Oxygen (Dioxygen)IBA 04/2000
1	SteroidsIBA 04/2000
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2000

Therapy/Procedure

3	Therapeutics 09/2003 - 04/2000
1	Colostomy 09/2018
1	Combined Modality Therapy 09/2018
1	Proctectomy 09/2018
1	Microbubbles 06/2003
1	Drug Therapy (Chemotherapy) 09/2000
1	Aftercare (After-Treatment) 08/2000
1	Continuous Positive Airway Pressure 04/2000